<VariationArchive RecordType="classified" VariationID="10966" VariationName="NG_009814.1:g.(?_4989)_(10173_?)del" VariationType="Deletion" Accession="VCV000010966" Version="1" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2022-09-10" DateCreated="2013-04-04" MostRecentSubmission="2013-04-04">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="26005" VariationID="10966">
      <GeneList>
        <Gene Symbol="NR0B1" FullName="nuclear receptor subfamily 0 group B member 1" GeneID="190" HGNC_ID="HGNC:7960" Source="submitted" RelationshipType="asserted, but not computed">
          <Location>
            <CytogeneticLocation>Xp21.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="30304206" stop="30309390" display_start="30304206" display_stop="30309390" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="30322538" stop="30327494" display_start="30322538" display_stop="30327494" Strand="-" />
          </Location>
          <OMIM>300473</OMIM>
          <Haploinsufficiency last_evaluated="2020-05-05" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=NR0B1">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2020-05-05" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=NR0B1">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NG_009814.1:g.(?_4989)_(10173_?)del</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>Xp21.3-p21.2</CytogeneticLocation>
      </Location>
      <OtherNameList>
        <Name>NR0B1, DEL</Name>
        <Name>DEL</Name>
      </OtherNameList>
      <HGVSlist>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_858" sequenceAccession="LRG_858">
            <Expression>LRG_858:g.(?_4989)_(10173_?)del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_009814.1" sequenceAccession="NG_009814" sequenceVersion="1" change="g.(?_4989)_(10173_?)del">
            <Expression>NG_009814.1:g.(?_4989)_(10173_?)del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="300473.0018" DB="OMIM" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NG_009814.1:g.(?_4989)_(10173_?)del AND Congenital adrenal hypoplasia, X-linked" Accession="RCV000011713" Version="6">
        <ClassifiedConditionList TraitSetID="3046">
          <ClassifiedCondition DB="MedGen" ID="C0342482">Congenital adrenal hypoplasia, X-linked</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="1997-11-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="1997-11-01" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2013-04-04" MostRecentSubmission="2013-04-04">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">9360549</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="3046" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="87" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">X-linked AHC</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Isolated X-Linked Adrenal Hypoplasia Congenita</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Congenital adrenal hypoplasia, X-linked</ElementValue>
                <XRef ID="Congenital+adrenal+hypoplasia%2C+X-linked/7542" DB="Genetic Alliance" />
                <XRef ID="237764004" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">ADRENAL HYPOPLASIA, CONGENITAL, WITH HYPOGONADOTROPIC HYPOGONADISM</ElementValue>
                <XRef Type="MIM" ID="300200" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Adrenal hypoplasia, congenital</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">X-AHC</ElementValue>
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">AHC</ElementValue>
                <XRef Type="MIM" ID="300200" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">AHCH</ElementValue>
                <XRef Type="MIM" ID="300200" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">NR0B1-related adrenal hypoplasia congenita includes both X-linked adrenal hypoplasia congenita (X-linked AHC) and Xp21 deletion (previously called complex glycerol kinase deficiency). X-linked AHC is characterized by primary adrenal insufficiency and/or hypogonadotropic hypogonadism (HH). Adrenal insufficiency is acute infantile onset (average age 3 weeks) in approximately 60% of affected males and childhood onset (ages 1-9 years) in approximately 40%. HH typically manifests in a male with adrenal insufficiency as delayed puberty (i.e., onset age &gt;14 years) and less commonly as arrested puberty at about Tanner Stage 3. Rarely, X-linked AHC manifests initially in early adulthood as delayed-onset adrenal insufficiency, partial HH, and/or infertility. Heterozygous females very occasionally have manifestations of adrenal insufficiency or hypogonadotropic hypogonadism. Xp21 deletion includes deletion of NR0B1 (causing X-linked AHC) and GK (causing glycerol kinase deficiency), and in some cases deletion of DMD (causing Duchenne muscular dystrophy). Developmental delay has been reported in males with Xp21 deletion when the deletion extends proximally to include DMD or when larger deletions extend distally to include IL1RAPL1 and DMD.</Attribute>
                <XRef ID="NBK1431" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute>
                <XRef ID="GTR000520059" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000576178" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="555" />
                <XRef ID="555" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301604</ID>
                <ID Source="BookShelf">NBK1431</ID>
              </Citation>
              <XRef ID="95702" DB="Orphanet" />
              <XRef ID="C0342482" DB="MedGen" />
              <XRef ID="MONDO:0010264" DB="MONDO" />
              <XRef Type="MIM" ID="300200" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="31945" SubmissionDate="2012-09-18" DateLastUpdated="2013-04-04" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="300473.0018_ADRENAL HYPOPLASIA, CONGENITAL" title="NR0B1, DEL_ADRENAL HYPOPLASIA, CONGENITAL" />
        <ClinVarAccession Accession="SCV000031945" DateUpdated="2013-04-04" DateCreated="2013-04-04" Type="SCV" Version="1" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="1997-11-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">By Southern blotting and PCR of a GGAA tetranucleotide tandem repeat, Nakae et al. (1997) detected deletions in the NR0B1 gene of 3 unrelated prepubertal patients with AHC (300200). The extents of the deletions were not determined. In 2 of the patients, the deletion was familial; in the third, it was de novo.</Attribute>
              <Citation>
                <ID Source="PubMed">9360549</ID>
              </Citation>
              <XRef DB="OMIM" ID="300200" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="NR0B1" />
          </GeneList>
          <Name>NR0B1, DEL</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">DEL</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="300473.0018" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">ADRENAL HYPOPLASIA, CONGENITAL</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="31945" TraitType="Disease" MappingType="Name" MappingValue="ADRENAL HYPOPLASIA, CONGENITAL" MappingRef="Preferred">
        <MedGen CUI="C0342482" Name="Congenital adrenal hypoplasia, X-linked" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

